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Chondrodysplastic dwarfism in Japanese brown cattle is an auto-
somal recessive disorder characterized by short limbs. Previously,
we mapped the locus responsible for the disease on the distal end
of bovine chromosome 6. Here, we narrowed the critical region to
2 cM by using linkage analysis, constructed a BAC and YAC contig
covering this region, and identified a gene, LIMBIN (LBN), that
possessed disease-specific mutations in the affected calves. One
mutation was a single nucleotide substitution leading to an acti-
vation of a cryptic splicing donor site and the other was a one-base
deletion resulting in a frameshift mutation. Strong expression of
the Lbn gene was observed in limb buds of developing mouse
embryos and in proliferating chondrocytes and bone-forming os-
teoblasts in long bones. These findings indicate that LBN is respon-
sible for bovine chondrodysplastic dwarfism and has a critical role
in a skeletal development.
Longitudinal growth of long bones arises from continuousproliferation and differentiation of chondrocytes followed by
endochondrial ossification at the epiphysial growth plates lo-
cated at both ends of long bone. Mutations of genes involved in
the process cause several types of dwarfism in human and mouse;
these findings have provided valuable insight into our under-
standing of skeletal development, a process we know very little
about (1–15).
Bovine chondrodysplastic dwarfism (BCD) in Japanese brown
cattle is an autosomal recessive disorder with the phenotype of
short limbs, joint abnormality, and ateliosis (16, 17). Long bones
of the affected animals have insufficient endochondrial ossifi-
cation with irregularly arranged chondrocytes, abnormal forma-
tion of the cartilaginous matrix, and partial disappearance of the
epiphysial growth plates. The axial skeletal structures and
craniofacial skeleton are not significantly affected. Dispropor-
tionate dwarfism also has been reported in other cattle breeds
including Dexter, Holstein, Aberdeen-Angus, Hereford, and
Shorthorn breeds (18, 19), but their clinical features, associated
with vertebral and craniofacial abnormalities, are different from
those of BCD.
In a previous study, we mapped the locus (bcd) responsible for
this disease in an 11-cM region between microsatellite markers
BP7 and BM9257 on the distal end of bovine chromosome
(BTA) 6 and demonstrated that the region corresponded to
human chromosome (HSA) 4p (20). Various genes responsible
for human hereditary diseases with skeletal abnormalities have
been localized to this region. For example, achondroplasia (7, 8),
hypochondroplasia (11), and thanatophoric dysplasia (15), char-
acterized by short-limb dwarfism, are caused by mutations in
fibroblast growth factor receptor 3 (MIM no. 134934). An
association between rare alleles of the MSX1 locus and limb
deficiency malformations has been suggested (MIM no. 142983;
ref. 21). EVC was identified recently as the gene responsible for
Ellis-van Creveld syndrome (MIM no. 225500), which is char-
acterized by short limbs, short ribs, postaxial polydactyly, and
dysplastic nails and teeth (22).
In the present study, we narrowed the bcd locus to a 2.4-cM
region, constructed yeast and bacterial artificial chromosome
(YAC, BAC) contigs covering this region, sequenced candidate
genes located in the region, and finally identified causative
mutations in a gene that is expressed in the epiphysial growth
plates of long bone.
Materials and Methods
Construction of Physical Map. A bovine YAC library was screened
by using a PCR-based method (23). A bovine BAC library
(RPCI-42) was screened by colony hybridization with high-
density filters purchased from Children’s Hospital (Oakland,
CA). YAC end sequences were obtained by the end rescue
method using the vectorette method, (24) and the BAC end
sequence was identified by direct sequencing of BAC DNA by
using T7 and SP6 primers with BigDye chemistry (Applied
Biosystems). Microsatellite loci were isolated by using biotin-
ylated (CA)12 probe, as described by Kijas et al. (25). The primer
sequences and PCR conditions to amplify microsatellites are
described in the GenBank database. Primer sequences of se-
quence-tagged site (STS) markers for bovine genes and ends of
clones are described in the supporting information, which is
published on the PNAS web site, www.pnas.org.
Pedigree Material and Haplotype Analysis. We used two paternal
half-sib pedigrees derived from sire A and sire B in a commercial
herd of Japanese brown cattle. Sire B is the offspring of sire A.
The pedigree of sire A was composed of sire A, 91 dams, 91
affected offspring, and 187 unaffected offspring. The pedigree of
sire B was composed of sire B, 28 dams, and 28 affected
offspring. We used 95 Japanese black and 106 Holstein cattle as
normal controls. The dwarf symptoms of the affected calves were
diagnosed by visual examination and by histologic examination
of growth plate cartilage after necropsy. Microsatellite genotyp-
ing was performed according to standard procedures (26). We
determined the most likely haplotype configurations as de-
scribed by Coppieters et al. (27).
Reverse Transcriptase (RT)-PCR. Total RNA of fetal calf long bone
was extracted with Trizol (Invitrogen) and reverse-transcribed
with SuperScript II Reverse Transcriptase using oligo-d(T)12 and
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random hexamers, according to the manufacturer’s instructions
(Invitrogen). The cDNAs were amplified with an annealing
temperature of 65°C using Avantage GC2 kit (CLONTECH),
according to the manufacturer’s instructions. To amplify bovine
EVC and geneX, we used primer pairs as follows: EVC, 5-
GTCCACTCAGTGCATCCTGC-3 and 5-AGGGCTCT-
GAGCAGTTGCCA-3; and geneX, 5-CTGGAGTCCACT-
GATGAACTGACC-3 and 5-CAATGTGAGAACCGAG-
AGCCTTGC-3.
Cloning of Bovine LBN cDNA. A fetal calf long bone cDNA library
(28) was screened by using standard methods with the RT-PCR
product of LBN as a probe amplified by a primer pair: bov1,
5-GAGAGAGGGTGATATTCTCTGG-3 and 5-GATAAA-
GAGCTTTTCACCCGTG-3. In addition, RT-PCR using bo-
vine fetal long bone total RNA was performed by using two sets
of primer pairs as follows: bov2, 5-GGCTTTCAGGAA-
GAAGTTTCTGC-3 and 5-CTCCAGGAGCTTCTGAC-
CCTTGC-3; and bov3, 5-GGAAGTATCTGGCCCATTTT-
GCC-3 and 5-CTCCAGCGAGGCTGTGTAGCTGAC-3.
The RT-PCR products were directly sequenced by using internal
primers. Sequencer software (Gene Codes, Ann Arbor, MI) was
used for the sequence assembly.
Human and Mouse Ortholog Cloning. The cDNA contig assembly of
human LBN was produced by using the RT-PCR and rapid
amplification of cDNA ends (RACE) methods (Invitrogen),
according to the manufacturer’s instructions using human kid-
ney total RNA (CLONTECH). The primers were designed
based on human genome draft sequences. The cDNA contig
assembly of mouse Lbn was produced by using the mouse
embryonic day (E)-11 limb buds -cDNA library (Stratagene)
screening and 5 RACE method with mouse embryo E14.5 total
RNA. We created multiple alignments of amino acid sequences
of LBN using GENETYX-MAC software (Software Development,
Tokyo). The protein sequences were analyzed by using the
programs SMART (available at http:smart.embl-heidelberg.de;
ref. 29) for transmembrane and coiled coil domain searches, and
PSORTII (available at http:psort.nibb.ac.jp; ref. 30) for protein
localization prediction.
Mutation Analysis. RT-PCR amplifications of bovine LBN cDNA
segments covering the entire coding region were performed by
using long bone total RNA derived from a 3-week old affected
and normal fetal calf with two sets of primer pairs as fol-
lows: bov4, 5-GCAAGGGTCAGAAGCTCCTGGAG-3 and
5-CAATGTGAGAACCGAGAGCCTTGC-3; and bov5, 5-
CGTCATTGTGCCTTTGGACTTTCAG-3 and 5-GCAG-
CATCGTCAGCTTCGACAGG-3. We used 38 PCR cycles
with an annealing temperature of 65°C, and the RT-PCR
products were sequenced by using internal primers. The genomic
segments containing a region of C1356T and 2054–2055del-
CAinsG mutations were amplified with primer pairs as follows;
bov6, 5-TACAGCAGGAGGAGGACCTTGC-3 and 5-
TTAGTTCACTGGAACCCAGCAC-3; and bov7, 5-GCCT-
GCAGAACTCAGGAATGAC-3 and 5-CGTGAAGAT-
CAAGTGCTCCCAGTG-3, respectively. We used 32 PCR
cycles with an annealing temperature of 58°C, and the products
were sequenced by using the same primers. For confirmation of
the mutations, the PCR products also were cloned in a pGEM-T
Fig. 1. Identification of bovine LBN gene. (A) Physical map consisting of YAC and BAC clones in the critical region on BTA 6. Informative and uninformative
markers in our pedigree, STS markers for genes and ends of the clones are shown in blue, green, red, and black, respectively. Dotted lines show regions
corresponding to HSA 4. (B) Transcription units on the human orthologous region on HSA 4p16. Genes and UniGene clusters localized by using the GRL database
are shown in red and purple, respectively. C4000112, C4000113, and C4000114 are putative exons on the UCSC human genome database. The black boxes indicate
a part of the human LBN gene. (C) Genomic structure of bovine LBN. M, translation initiation codon; *, stop codon.
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Easy vector (Promega) according to the manufacturer’s instruc-
tions and sequenced.
Expression Analysis. Northern blots contained 2 g of mouse
poly(A) RNA from adult tissues (MNT filter, CLONTECH),
long bone and cranial bone from postnatal day (P)-14 and whole
embryos at various stages. A mouse Lbn cDNA fragment
(nucleotides 266-2086) was used as a probe for hybridization. We
probed the same set of filter with a G3pdh probe as a loading
control. Whole-mount in situ hybridization was performed ac-
cording to the protocol described by Conlon and Rossant (31).
The digoxigenin (DIG)-labeled riboprobes corresponding to the
5 region of mouse Lbn cDNA (nucleotides 149-1558) was used.
For in situ hybridization analysis, mouse tibias at E17 and P35
were fixed in 4% (volvol) paraformaldehyde in PBS overnight
at 4°C and decalcified in 10% (wtvol) EDTA for 1 day and 7
days, respectively. Specimens were embedded in paraffin and
sectioned at 6m. DIG-11-UTP-labeled riboprobes correspond-
ing to the 3 region of mouse Lbn cDNA (nucleotides 2801–3044)
were prepared by using a DIG RNA labeling kit (Roche
Molecular Biochemicals), according to the manufacturer’s in-
struction. Hybridization was performed overnight at 48°C with
washes at 50°C as described by Ikegame et al. (32). Cell nuclei
were stained with 1% (wtvol) methyl green.
Results
Fine Genetic and Physical Mapping. We constructed a bovine
radiation hybrid (RH) map of BTA 6 by using a bovine-hamster
whole-genome RH panel (33) and identified that the critical
11-cM region from BP7 to BM9257 corresponded to HSA 4p16
and 4q21 (M.T., unpublished data). To refine further the bcd
locus, we constructed YAC and BAC clone contigs by using STS
markers amplifying inserts of the clones as well as bovine
orthologs of genes located in HSA 4p16 and 4q21 and developed
14 polymorphic microsatellite markers (DIK1178-DIK1190, and
DIK1192) from the clones (Fig. 1A). We genotyped a paternal
half-sibling pedigree of 119 affected calves using the markers to
determine the precise localization of bcd and the disease-
associated haplotypes. None of the affected calves had recom-
bination with DIK1183 and DIK1184, narrowing the critical
Fig. 2. Pedigrees with BCD and haplotypes consisting of nine markers in the critical region on BTA 6. Green, haplotype associated with a C1356T mutation;
yellow, haplotype associated with a 2054–2055delCAinsG mutation. The number of animals is shown in parentheses. (A) This pedigree includes grandsire A and
sire B, which were identified as carriers of the disease, 90 affected offspring, 90 dams of the affected offspring, and some ancestors. The shaded diamonds
represent affected offspring. White with diagonal line denotes animals not genotyped. (B) Haplotypes of nine microsatellites (Left) for grandsire A, sire B, and
the 119 affected offspring are shown.
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region to 2.4 cM between DIK1182 and DIK1185 (Fig. 2B).
Interestingly, the haplotypes of the most affected calves (111
119) were heterozygous for two specific haplotypes (Fig. 2),
suggesting that both haplotypes were responsible for BCD and
that two distinct mutations associated with these haplotypes
might be present in the population of Japanese brown cattle.
Candidate Gene Identification. As shown in Fig. 1 A and B, the gene
order from PPP2R2C to MSX1 covering the critical region is
conserved between cattle and human. In this region, the human
genome database GRL (http:grl.gi.k.u-tokyo.ac.jp; ref. 34)
disclosed four genes (CRMP1, EVC, C4orf6, and HSA250839)
and six human UniGene clusters (Hs.256259, Hs.257022,
Hs.87306, Hs.192146, Hs.133062, and Hs.122053; Fig. 1B). We
examined the expression of these possible candidate genes in
long bones of fetal calves with RT-PCR andor Northern
hybridization. Among them, EVC and bovine expressed se-
quence tag AW345074 (designated geneX), an ortholog of
Hs.87306, were expressed in long bones of fetal calves (data not
shown), suggesting that these two genes were the most potent
candidate genes for BCD. No causative mutation was found,
however, in the bovine EVC gene by sequencing the entire
coding region of the gene of affected animals (data not shown).
To characterize the complete coding sequence of geneX, we
isolated two clones from a bovine fetal long bone cDNA library
with AW345074 as a probe, covering a 1,775-bp region of geneX
containing a poly(A) tail but not the 5 region of the coding
sequence. As of April 1, 2001, the University of California Santa
Cruz (UCSC) human genome database (http:genome.
ucsc.edu) located three predicted exons C4000112, C4000113,
and C4000114 upstream of Hs.87306, a human ortholog of geneX.
We confirmed that the three predicted exons were included in
human geneX transcript with RT-PCR by using human kidney
RNA (data not shown). Bovine sequences corresponding to
C4000112, C4000113, and C4000114 were determined by shot-
gun sequencing of bovine BAC 162M16 and 232M6. Primers for
amplifying the 5 region of the cDNA were designed from these
sequences. The nucleotide sequences of the RT-PCR products
using these primers allowed reconstruction of a 5,759-base
transcript containing a putative 3630-base ORF (position 1686–
5315). geneX encoded a protein consisting of 1209 amino acids
(see Fig. 6, which is published as supporting information on the
PNAS web site, www.pnas.org). To determine the genomic
structure of the gene, we sequenced bovine BAC 232M6 and
162M16 using primers designed from the cDNA sequence and
identified that the gene consists of 22 exons (Fig. 1C). The
human and mouse orthologs also were isolated by a combination
of cDNA cloning, RT-PCR, and RACE. The human and mouse
geneX encode 1,228 amino acids with 78.7% homology, and 1,220
amino acids with 68.4% homology with bovine geneX, respec-
tively (Fig. 6). The SMART (29) and PSORTII (30) program
searches suggested that a putative transmembrane domain, two
coiled-coil domains, and three nuclear localization signals were
conserved between cattle, human, and mouse genes (Fig. 6).
Identification of Two Mutations in the Gene. We examined the
expression of geneX in the long bones of normal and affected
calves using RT-PCR; there was no qualitative difference ob-
served (data not shown). Expression of geneX was not detected
by Northern hybridization, probably because of the low level of
expression (data not shown).
To determine whether mutations in geneX cause BCD, we
Fig. 3. Mutation analysis in bovine LBN gene. Sequence chromatograms of affected calves having heterozygous haplotypes (Left), normal calves (Center), and
subcloned mutant alleles (Right). Amino acid sequence changes caused by mutations. (A) cDNA sequence in exon 11. A 56-bp deletion is observed at position
1355–1410 in the mutant allele, which is schematically illustrated. The deletion causes a frameshift, producing a premature termination at codon 464 with an
extension of 10 aberrant amino acids. (B) Genomic sequence in exon 11. C to T substitution is observed at position 1356 in the affected calf (C1356T), which creates
a cryptic splice donor site in exon 11 and leads to the improper splicing identified in the affected cDNA sequence. (C) cDNA and genomic sequences in exon 14.
CA to G substitution is observed at positions 2054 and 2055 in the mutant allele (2054–2055delCAinsG), which causes a frameshift producing a premature
termination at codon 706 with an extension of 21 aberrant amino acids.
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compared the nucleotide sequences of geneX between normal
and affected calves, and identified two distinct mutations in the
affected calves. One mutation was a 56-base deletion at position
1355–1410 in exon 11 (Fig. 3A). The deletion caused a frameshift
and a premature termination at codon 464, resulting in a 62%
shortened protein. Comparison of the genomic sequence of the
region between the affected and normal calves revealed no
differences in the nucleotide sequence except for a C to T
transition at position 1356 (C1356T; Fig. 3B). Remarkably, the
C1356T mutation created a cryptic splice donor site in exon 11
(AAGGT1356GAGC) that substituted for the authentic splice
donor site and led to improper splicing at position 1355, resulting
in the 56-base RNA deletion between 1355 and 1410. The second
mutation was a CA to G substitution at position 2054–2055
(2054–2055delCAinsG; Fig. 3C). The substitution also caused a
frameshift and a premature termination at codon 706, resulting
in a 42% shortened protein. We confirmed the CA to G
substitution in the genomic DNA of the affected calves.
To confirm whether the mutations cosegregate with the
phenotype and whether these two mutations are distinct alleles
of the gene, we performed a direct sequencing analysis of all
affected and unaffected animals of the pedigree as well as
animals of unrelated populations (see Table 1, which is published
as supporting information on the PNAS web site). All 119
affected calves were either homozygous for 2054–2055del-
CAinsG or compound heterozygous for C1356T and 2054–
2055delCAinsG. The two sires of the affected offspring were
carriers of 2054–2055delCAinsG, and the dams were carriers of
either of the two mutations. The result was consistent with that
of the haplotype analysis (Fig. 2). All 187 unaffected relatives
had one or two chromosomes carrying the wild-type allele.
Furthermore, no mutation was observed in 201 animals of the
unrelated populations (106 calves of Holstein and 95 calves of
Japanese black cattle), confirming that these mutations are
specific to the disease. These data provide strong evidence that
both mutations are distinct alleles of geneX and are responsible
for BCD. We designated this gene LIMBIN (LBN), because the
BCD disorder was characterized as the formation of short limbs.
Expression of Mouse Lbn. We examined the expression of the Lbn
gene in mouse tissues to evaluate the potential roles of the gene
in the development of long bone. Northern blot analysis revealed
that Lbn was expressed as an 4.5-kb mRNA in long bone,
cranial bone, kidney, heart, and embryos at E7, E11, E15, and E17
(Fig. 4A). Whole-mount in situ hybridization showed that Lbn was
expressed in fore- and hindlimb buds, branchial arches, and facial
primordia at the limb bud formation stage, E11 (Fig. 4B), suggesting
Fig. 5. Lbn expression in mouse long bones. In situ hybridization with Lbn
antisense probe (Left) and sense probe as a control (Right). (A–D) Mouse tibia at
E17. Lbn is expressed strongly in proliferating chondrocytes and weakly in other
resting and hypertrophic chondrocytes in the epiphysial growth plates. (E–J)
Mouse tibia at P35. Lbn is expressed strongly in proliferating chondrocytes in the
epiphysial growth plates, osteoblasts, and osteoclasts and weakly in osteocytes in
the metaphysis. RC, resting chondrocytes; PC, proliferating chondrocytes; HC,
hypertrophic chondrocytes; OB, osteoblasts; OCL, osteoclasts; OCY, osteocytes;
BM, bone marrow. The magnification is shown on the right.
Fig. 4. Lbn expression in mouse tissues. (A) Northern blot analysis. An
4.5-kb Lbn mRNA can be seen in heart and kidney in adult, long bone, and
cranial bone at P14 and whole embryos at all stages tested. An additional
7.0-kb band is faintly visible in kidney. (Lower) Loading controls with a
G3pdh probe. (B) Whole-mount in situ hybridization with Lbn antisense probe
(Left) and sense probe as a control (Right). A definite signal is observed in fore-
and hindlimb buds (arrow), branchial arches, and facial primordia. The mag-
nification is 12.5.
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that Lbn has a role in early embryonic morphogenesis as well. In situ
hybridization analysis using mouse tibia at E17 revealed that mouse
Lbn was strongly expressed in proliferating chondrocytes, and
weakly in other resting and hypertrophic chondrocytes in the
epiphysial growth plates (Fig. 5 A and C). At P35, Lbn also was
expressed in proliferating chondrocytes, but not in resting and
hypertrophic chondrocytes (Fig. 5 E and G). In the metaphysis, the
expression was observed strongly in osteoblasts and osteoclasts on
the bone surface and weakly in osteocytes (Fig. 5I). These data
implicate involvement of the Lbn gene in the formation and growth
of long bones.
Discussion
In the present study, we identified the gene LBN as a causative
gene for BCD. This conclusion is supported by the following
evidence: (i) the position of the LBN gene on cattle chromo-
some, (ii) two frameshift mutations causing 62% and 42%
deletion of the LBN protein, (iii) the perfect cosegregation of the
mutations with the phenotype, and (iv) expression of LBN in the
limb buds and growth plate chondrocytes. Although the function
of LBN remains unknown, LBN should have essential roles for
a skeletal development.
Mouse Lbn was strongly expressed in the proliferating chon-
drocytes in mouse tibia (Fig. 5 C and G). Several ligands and
their receptors, including Indian hedgehog, PTH-related pep-
tide, PTHPTH-related peptide receptor, fibroblast growth
factor receptor 3, and others are expressed in proliferating
andor prehypertrophic chondrocytes and regulate chondrocytic
proliferation and differentiation that are critical to bone mor-
phogenesis (35–38). In addition, extracellular matrix proteins
such as proteoglycan and collagen have important roles in
normal bone development (1–3, 39). As long bones of the
affected animals show a disturbance in chondrocytic differenti-
ation and abnormal formation of cartilaginous matrix (17), the
loss of function of LBN might have a direct or indirect effect on
proliferating chondrocytes through interactions with these fac-
tors and disturb a proper differentiation to hypertrophic chon-
drocytes to form a proper cartilaginous matrix. Moreover, the
expression of mouse Lbn was observed in cranial bone, osteo-
blasts, osteoclasts, osteocytes, and kidney (Figs. 4A and 5I),
suggesting that Lbn has a role in osteogenesis andor Ca2
homeostasis as well.
LBN might have a positional relation to EVC. LBN and EVC
genes are both responsible for short-limb disorder (22) and are
arranged in a head-to-head configuration in cattle, human, and
mouse, with transcription-start sites separated by 1,869 and
1,754-bp in human and mouse, respectively. In addition, LBN
and EVC genes have similar expression patterns. Ruiz-Perez et
al. (22) reported that EVC is expressed in human fetal tissues
including developing bone, heart, kidney, and lung at Carnegie
stages 19 and 21. We also demonstrated that mouse Lbn is
expressed in developing bone and adult heart and kidney (Fig.
4A). Because of the contiguous genomic organization and sim-
ilarity of expression patterns, both genes might be coexpressed
and coregulated by common sequences within the intervening
region. Kunte et al. (40) reported that UFD1L and CDC45L
genes expressed in limb buds and pharyngeal arches are arranged
in a head-to-head configuration, and an 884-bp intervening
region could direct bidirectional transcription activation of both
genes in a neural crest-derived cell line.
LBN is a gene involved in bone formation and shows no
structural homology with any other known gene. Future studies
of LBN, both in vivo and in vitro, and further pathological
examination of BCD will provide new insight into the complex
biologic processes of mammalian skeletal development.
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